During the past decade, South Texas Health Care System, San Antonio, TX conducted 39 clinical trials. In the 10-year time frame, 39 clinical trials started and 35 clinical trials were completed, i.e. on average, 89.7% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 13 clinical trials were completed. i.e. 92.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "South Texas Health Care System, San Antonio, TX" #1 sponsor was "VA Office of Research and Development" with 33 trials, followed by "US Department of Veterans Affairs" with 18 trials sponsored, "The University of Texas Health Science Center at San Antonio" with 15 trials sponsored, "National Institute of Allergy and Infectious Diseases (NIAID)" with 5 trials sponsored and "Otsuka Pharmaceutical Development & Commercialization, Inc." with 5 trials sponsored. Other sponsors include 14 different institutions and companies that sponsored additional 24 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "South Texas Health Care System, San Antonio, TX" #1 collaborator was "South Texas Veterans Health Care System" with 8 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 4 trials as a collaborator, "American Diabetes Association" with 3 trials as a collaborator, "The University of Texas Health Science Center at San Antonio" with 3 trials as a collaborator and "AstraZeneca" with 2 trials as a collaborator. Other collaborators include 64 different institutions and companies that were collaborators in the rest 68 trials.

According to Clinical.Site data, the most researched conditions in "South Texas Health Care System, San Antonio, TX" are "HIV Infections" (6 trials), "Heart Failure" (4 trials), "Type 2 Diabetes Mellitus" (4 trials), "Diabetes" (3 trials) and "Multiple Myeloma" (3 trials). Many other conditions were trialed in "South Texas Health Care System, San Antonio, TX" in a lesser frequency.

Most popular intervention types in "South Texas Health Care System, San Antonio, TX" are "Drug" (41 trials), "Other" (21 trials), "Behavioral" (11 trials), "Device" (10 trials) and "Procedure" (9 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Atropine" (2 trials), "Exendin-(9-39)" (2 trials), "Rosiglitazone" (2 trials) and "Vancomycin" (2 trials). Other intervention names were less common.

The vast majority of trials in "South Texas Health Care System, San Antonio, TX" are 87 trials for "All" genders, 4 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are 19 active trials in "South Texas Health Care System, San Antonio, TX". 3 are not yet recruiting, 14 are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 63 completed trials in South Texas Health Care System, San Antonio, TX, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in South Texas Health Care System, San Antonio, TX, 1 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 12 trials, and there were also 30 trials that are defined as “Not Applicable".